Exactus renamed Panacea Life Sciences; 1-for-28 reverse split; Series C-2 preferred issued to cancel 205M shares

PANACEA LIFE SCIENCES HOLDINGS, INC.

Company changed name to Panacea Life Sciences Holdings, Inc., effective Oct 25, 2021.
Effected 1-for-28 reverse stock split of common stock.
Designated 100 shares of Series C-2 Convertible Preferred stock, each convertible into 2,050,000 common shares.
Issued all 100 Series C-2 shares to Quintel-MC Inc., owned by CEO Leslie Buttorff, in exchange for canceling 205,000,000 common shares.
CEO Leslie Buttorff is sole owner, officer, and director of Quintel.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.